OBJECTIVE: To study the role of dopamine in the ventromedial hypothalamus (VMN) in the regulation of meal size and meal number during obesity. METHODS: Embryonic mesencephalic cells rich in dopaminergic neurons from lean rats were grafted into the VMN of obese Zucker rats. Since food intake is the product of meal size and number, these variables were measured using a rat`eater meter'. Dopamine and serotonin concentrations in the VMN were assayed in grafted and control rats via in vivo microdialysis and HPLC two months after transplantation. RESULTS: Food intake increased in grafted rats due to an increase of both meal size and meal number 2 weeks after implantation and to an increase of meal size with insuf®cient compensatory decrease of meal number 2 months after transplantation. Grafted rats showed higher absolute dopamine and lower serotonin concentrations in the VMN. CONCLUSION: It would appear that an increase of dopamine and a decrease of serotonin in the VMN of grafted obese rats may correlate with increase in meal number and meal size, respectively. Since obese Zucker rats usually display an enlarged meal size, we deduce from the data that chronically elevated VMN dopamine and low serotonin are involved in producing the large meal size observed during obesity.
Introduction
Central regulation of food intake involves complex relationships between neuropeptides, monoamines and other brain messengers and basically occurs in the hypothalamus. Because food intake consists of meal size multiplied by meal number which constitutes a feeding pattern, 1 the separate analysis of each component, as it relates to change in neurochemical messengers, is of particular interest because it re¯ects the physiological signi®cance of meal size as it relates to satiation and meal number as it relates to satiety respectively. 2, 3 Any variable that affects food intake must do so via one or both of these indexes. The study as to how these indexes are affected by speci®c variables may reveal considerable information concerning the mechanisms responsible for the regulation of food intake.
Genetic obesity is a metabolic disorder, which includes increased appetite, and whose mechanism is under investigation and can be similar for both genetic and acquired obesity. Among the many appetiterelated brain messengers, dopamine (DA) has been shown to be an important signal. The absence of DA production in the knockout mouse model, which lacks tyrosine hydroxylase expression, 4 caused an inability to initiate feeding that can be restored by tyrosine hydroxylase gene delivery into the striatum. 5 Hence, DA has been postulated to be required to initiate each meal, 6 and thus can be associated with meal number at least in its action in the forebrain.
An increase of dopamine in the medial hypothalamus, the area of neuroendocrine and autonomic regulation of metabolism, was reported to accompany food intake 7 . Lesions of the medial hypothalamus are known to produce both hyperphagia and morbid obesity, 8 suggesting that dopamine in the medial hypothalamus could be involved in the regulation of both food intake and body weight set point.
To explore the role which medial hypothalamic DA can play in the regulation of food intake during obesity we used neurotransplantation as a tool in the genetically obese Zucker rat in which the main cause of obesity is thought to be related to leptin receptor mutation. 9 We hypothesized that a long-term overrelease of endogenous dopamine from the graft in the ventromedial nucleus of hypothalamus (VMN) of obese male Zucker rats will not only lead to a change in food intake but will do so by selective change in meal size or meal number. This hypothesis was based on reported relationships between changes in hypothalamic dopamine concentration occurring during feeding. 10, 11 The neurotransplantation method is based on the ability of grafted embryonic neurons to express their phenotype in a new microenvironment and for axonal growth to their target cells. 12 Thus, we grafted a suspension of embryonic ventral mesencephalic tissue rich in dopaminergic neurons from lean Zucker rats into the VMN of obese Zucker rats and studied their feeding pattern before and after the transplantation.
Materials and methods

Subjects
The experiments were approved by the State University of New York Health Science Center at Syracuse Committee for the Humane Use of Animals and animal care was in accordance with guidelines established by the National Institutes of Health. Rats were purchased from Department of Nutrition, University of California, Davis. Male obese (faafa) Zucker rats (90 g, 5 weeks old) were used as hosts and were housed in holding wire mesh cages for 1 week after purchase to acclimate them to the constant study environmental conditions: 12h light cycle (06.00 ± 18.00 h) 26 AE 1 C room temperature, 45% humidity. They were fed a standard rat chow (Diet 5008; Ralston Purina, St Louis, MO). Food and tap water were available ad libitum. Homozygous (FaaFa) lean Zucker fetuses were used as donors and were obtained from pregnant homozygous (FaaFa) lean Zucker females at 14 ± 15 days gestation (e14 ± e15) after mating with homozygous (FaaFa) lean Zucker males.
Measurement of food intake, meal size and meal number
One week after purchasing, obese Zucker rats were individually placed into cages equipped with the automated computerized rat`eater meter' (ACREM) as previously described in detail and speci®cally developed in this laboratory. 13 It continuously measures the feeding indexes of meal size, meal number, as well as food intake for both dark and light cycles and for 24 h. Rats were studied in ACREM equipped cages for 2 weeks beginning 2 months after transplantation. Body weight of the rats was measured every 4 days.
Neurotransplantation
Obese rats were divided into two groups, each of eight rats. The experimental rats were implanted bilaterally into the VMN with a cell suspension of ventral mesencephalic tissue as the source of dopaminergic neurons (DA graft). Control obese rats were shamoperated. The fetuses were dissected from the uterus, placed in Hanks' balanced salt solution (Sigma Chemicals, St Louis, MO) at 4 C and used within 4 h for transplantation. Meninges were removed and the fetal brains were excised under a dissecting microscope.
The dissection of fetal tissue and preparation of cell suspension were carried out according to the basic neural transplantation technique described by Dunnet. 14 For the graft implantation, host rats were anesthetized with mixture of ketamine, xylazine, and acepromazine (150:30:5 mgaml) at 0.8 mlakg body weight. The cell suspension (volume 2 ml) was loaded into the lumen of a stainless steel cannula, with an external diameter 0.8 mm. The cannula was stereotaxically 15 (Kopf Instrument, Tujunga, CA) placed into the bilateral VMN (incisors bar 4 mm; 0.2 mm anterior to the bregma; 0.6 mm from the middle line; 8.0 mm below the dura mater) and the cell suspensions were pushed out of the cannula with a stainless steel plunger (2 mlamin). Sham operation consisted of bilateral injection of 2 ml Hanks' solution in the VMN using the same stereotaxic coordinates.
As an additional control a cell suspension of rombencephalic tissue was grafted into the VMN (data not shown, because grafted rats did not differ from controls). In a further experiment a cell suspension of ventral mesencephalon labeled before implantation with vital¯uorescent marker SP-DiIC 18 (Molecular Probes, Eugene, OR) added in 2 mM concentration in working media during preparation of neural cell suspension was injected into the VMN of ®ve rats, to con®rm the location of grafted cells in the host brain.
In vivo assay of dopamine and serotonin Surgery. DA-grafted (n 5) and control rats (n 6) 2 months after transplantation or sham operation were anesthetized with a mixture of ketamine, xylazine and acepromazine (150:30:50 mgaml at 0.8 mlakg body weight given intramuscularly) and placed in a stereotaxic frame (Kopf Instruments) with the horizontal zero plan tangential to the upper incisor bar and 5.0 mm above the interaural line. An intracerebral cannula guide was placed into the VMN using the stereotaxic coordinates: 0.2 mm anterior to the bregma; media-lateral, 0.8 mm from the middle line; and dorsal-ventral, 8.9 mm ventral from the surface of the dura mater. The cannula guide was ®xed to the skull with acrylic dental cement. After operation, each rat was kept individually in a plastic metabolic cage (Nalgene Company, Rochester, NY) during a 10-day recovery period.
Microdialysis and HPLC. The CMAa10 microdialysis probe was used (BAS, West Lafayette, IN). The microdialysis membrane was 1 mm long, 400 mm i.d., 520 mm o.d. and 20 kDa molecular weight cutoff. According to our in vitro calibration test, the relative recovery rate for DA and 5-HT was about 10 ± 12% at a¯ow rate of 1 mlamin. A Ringer solution containing 147.0 mM Na , 2.4 mM Ca 2 , 4.0 mM K and 155.8 mM C1 7 was used for perfusing by a Experimental procedure. Rats were food deprived for 12 h. Beginning at 7:00 a.m., the rat was placed into a bowl-like cage (CMAa120 Awake Animal System, BAS, West Lafayette, IN) and a microdialysis probe was inserted into the guide cannula, extending 1 mm beyond the cannula into the VMN. After a 4 h stabilization period, 20-min samples were collected for 1 h, and DA and 5-HT concentrations were immediately measured.
Data analysis
Data are expressed as mean AE s.e. Data were analyzed using ANOVA and paired Student's t-test. The analysis of food intake, meal size and meal number was based on cumulative data including two periods: before and after transplantation. Analysis of diurnal distribution of food intake was also performed.
Histological examination of the brain
At the end of the experiment grafted rats were anesthetized using the same type of anesthesia (1.0 mlakg body weight), and then were perfused via the ascending aorta with 100 ml (at 37 C) of 0.9% NaCl solution followed by 200 ml of ice-cold 4% paraformaldehyde in 0.1 M phosphate buffer. Brains were rapidly dissected out, immersion-®xed overnight, and then were cut with a Vibratome into 100 mm thick frontal sections. To verify the location of microdialysis probe, sections were stained with Hematoxylin (Vector Laboratories, Burlingame CA) and analyzed under an optic microscope. The brain sections of rats grafted with SP-DiIC 18 labeled cells were examined under a¯uorescence microscope and photographed.
Results
Histological examination of the brain
Analysis of brain sections demonstrated the correct location of the microdialysis probe inside of the VMN for all rats. SP-DiIC 18 -labeled cells were observed forming an aggregation inside of the VMN (Figure 1 ). Figure 2 demonstrates body weight gain of the DAgrafted and control rats. It also shows experimental schedule as to when rats were studied in the ACREM. There were no differences in body weight between study and control groups of rats before transplantation. However, starting during third week after transplantation, body weight in DA-grafted rats signi®cantly increased (DA grafted rats 373.1AE 7.7 g vs control rats 356.2AE 5.1 g; P`0.05) and the increase persisted throughout the remaining experiment. Two months after transplantation, the body weight of DA grafted rats exceeded that of the controls by 6% (DA grafted rats 560.7AE 11.9 g vs control rats 524.3AE 12 g; P`0.05).
Body weight
Food intake, meal size and meal number
Analysis of the ACREM data revealed that, before transplantation, there were no differences in food intake between study and control groups of rats. Two weeks after transplantation, DA grafted rats as 
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SO Fetissov et al compared to controls started to display an elevated food intake (the mean of daily food intake during 1 week: DA grafted rats 28.2AE 0.8 gaday, control rats 24.9 AE 0.9 gaday; P`0.05). The elevation of food intake was 14% on average, with equal contribution from meal size and meal number ( Figure 3A ). Diurnal analysis of food intake demonstrated that its increase in DA grafted rats corresponds to two diurnal peaks of eating activity. Two months after transplantation the rats were studied again in the ACREM equipped cages. As compared to the controls, food intake in DA grafted rats was increased by 5% due to a 20% increase in meal size. A 10% decrease in meal number was also observed ( Figure 3B ). The mean of daily food intake during 1 week was: DA-grafted rats 21.6 AE 0.4 gaday vs control rats 20.5AE 0.3 gaday; P`0.05.
In vitro assay of dopamine and serotonin
The mean of cumulative dopamine concentrations in the VMN (Figure 4 ), collected during 1 h of microdialysis, was higher in DA grafted rats as compared with controls (0.181 AE 0.046 pgaml vs 0.023AE 0.009 pgaml, respectively; P`0.01). The mean of serotonin concentrations was lower in DA grafted rats than in control rats (0.016AE 0.002 pgaml vs 0.024AE 0.002 pgaml respectively; P`0.02).
Discussion
In the present study, the correct location of the embryonic grafts inside the VMN and elevated in vivo concentration of dopamine in the VMN shed light on the role of dopamine in the VMN as it relates to food intake, meal size and meal number during obesity.
In the brain the role of DA is not restricted to food intake and the computation of its actions led Berridge and Robinson to conclude that DA is important in incentive salience attributions to the neural representations of reward-related stimuli. 6 This conclusion concerned mainly nigro-striatal and meso-limbic DA, while the hypothalamus possesses its own incertoinfundibular dopaminergic system and consequently this system can be activated independently. However, the origin of the detected dopamine in the VMN is not clear: it could be mesencephalic or hypothalamic or a mixture of both. Nevertheless DA in the hypothalamus targets the neurons involved in the autonomic and neuroendocrine regulation of metabolism and consequently DA's effect on food intake should be different from that in the forebrain. Therefore, if in the striatum the reestablishment of the continuous release of DA stimulates feeding, 5 in the lateral hypothalamic area (LHA) DA administration inhibits feeding 16 by inhibiting meal size. 17 LHA and VMN are known to be involved reciprocally in the regulation of food intake and energy metabolism. 18, 19 The acute administration of DA into the medial hypothalamus as well as into the nucleus accumbens was ineffective in changing food intake, 16 while the microdialysis demonstrated feed- Figure 3 The mean of total daily food intake, meal size and meal number during 1 week in grafted vs control (100%) Zucker rats, after 2 weeks (A) and after 2 months (B) following transplantation or sham operation. VMN graft in Zucker rats SO Fetissov et al ing-related changes of DA concentration in both areas. 3, 7, 11, 20 These data suggest that in both the VMN and the forebrain long-term rather than acute change of DA concentrations can in¯uence the formation of feeding pattern. Our work provides supporting evidence showing an increase of both meal size and meal number, which accompanied a long-term over-release of VMN DA.
In the present study, an increase in food intake in grafted rats began on the eight day after transplantation. This suggests that, within the ®rst week, grafted neurons complete their differentiation and start their secretory activity. Although we did not measure dopamine concentration in the VMN at the beginning, when an increase in food intake occurred in the grafted rats, we postulate that this increase was due to elevated dopamine concentrations produced by the grafted cells, which when measured 2 months after transplantation were found to be elevated. Moreover, we suppose that grafted neurons released more dopamine in the surrounding tissue 2 weeks after transplantation than in the later period, when they can be regulated by the host brain.
Because an increased meal size was the common contributor to the increased food intake that was measured 2 weeks as well as 2 months after the transplantation, we conclude that meal size might be upregulated by the chronically elevated dopamine levels in the VMN. However, this effect of elevated dopamine on meal size can be indirect. Dopamine inhibits serotonin release in the substantial nigra; 21 if a similar mechanism exist in the VMN, then in the present study, a high concentration of dopamine may have caused low serotonin concentration of the VMN of the grafted rats, as was detected. Therefore, the previously reported role of VMN serotonin to inhibit meal size, 22 presents an explanation of the change in feeding pattern of grafted rats via the primary effect of serotonin on the meal size. Under normal conditions, meal size and meal number are reciprocally regulated in order to keep daily food intake constant. 1 However, the increase in meal size observed in the present study failed to be offset for by a suf®cient compensatory decrease of meal number. Yet, meal number was increased 2 weeks after the transplantation. Consequently we postulate that meal number regulatory mechanism was also targeted independently from that of meal size, and where an increased dopamine concentration can be involved directly, as we previously suggested. 3 In several reports no differences in basal VMN DA concentration were found between obese and lean Zucker rats, 23, 24 but an exaggerated VMN DA response to eating occurred in the obese Zucker rats. 25 This raises the question whether higher DA concentration in obese Zucker rats vs lean rats occur only during eating, or whether the cumulative effect of higher DA concentration contributes to the pathogenesis of hyperphagia and obesity. The data from this experiment would support the latter and also suggests that VMN DA is involved in the formation of both meal number and meal size via possible interaction with serotonin. These ®ndings dissociate the role of DA in the VMN from both the forebrain and the LHA, as it relates to food intake.
It is possible that, via long-term action, VMN DA can modulate the activity of peptidergic neurons, associated with the regulation of feeding pattern providing the constancy of daily food intake to maintain body weight set point. However it is not known if DA release in the VMN re¯ects a unique homeostatic signal or an integrative signal, activated by a broad range of food intake-related physiological stimuli.
In summary, the present study demonstrates that rats grafted with embryonic dopaminergic cells into the bilateral VMN increase meal size, meal number, food intake and body weight, which re¯ects the phenotype of Zucker obesity with exaggerated characteristics of the feeding pattern. This phenotype was characterized by increased VMN dopamine and decreased VMN serotonin concentrations, emphasizing their roles and interrelation in the regulation of meal number and meal size during obesity.
